Department of Biochemistry, Schulich School of Medicine & Dentistry, University of Western Ontario, London, ON N6A 5C1, Canada.
Mol Cell Biochem. 2011 Oct;356(1-2):159-67. doi: 10.1007/s11010-011-0972-5. Epub 2011 Jul 13.
Apoptosis, or programmed cell death, is a vital cellular process often impaired in diseases such as cancer. Aspartic acid-directed proteases known as caspases cleave a broad spectrum of cellular proteins and are central constituents of the apoptotic machinery. Caspases are regulated by a variety of mechanisms including protein phosphorylation. One intriguing mechanism by which protein kinases can modulate caspase pathways is by blocking substrate cleavage through phosphorylation of residues adjacent to caspase cleavage sites. To explore this mechanism in detail, we recently undertook a systematic investigation using a combination of bioinformatics, peptide arrays, and peptide cleavage assays to identify proteins with overlapping protein kinase and caspase recognition motifs (Duncan et al., Sci Signal 4:ra30, 2011). These studies implicated protein kinase CK2 as a global regulator of apoptotic pathways. In this article, we extend the analysis of proteins with overlapping CK2 and caspase consensus motifs to examine the convergence of CK2 with specific caspases and to identify CK2/caspase substrates known to be phosphorylated or cleaved in cells. Given its constitutive activity and elevated expression in cancer, these observations suggest that the ability of CK2 to modulate caspase pathways may contribute to a role in promoting cancer cell survival and raise interesting prospects for therapeutic targeting of CK2.
细胞凋亡,又称程序性细胞死亡,是一种重要的细胞过程,常发生于癌症等疾病中。天冬氨酸导向的蛋白酶,即半胱氨酸蛋白酶,可切割广泛的细胞蛋白,是细胞凋亡机制的核心组成部分。半胱氨酸蛋白酶受到多种机制的调节,包括蛋白磷酸化。蛋白激酶可以通过磷酸化临近半胱氨酸切割位点的残基来阻断底物切割,从而调节半胱氨酸蛋白酶途径,这是一种有趣的机制。为了详细研究这一机制,我们最近采用生物信息学、肽阵列和肽切割测定的组合,对具有重叠蛋白激酶和半胱氨酸蛋白酶识别基序的蛋白质进行了系统研究(Duncan 等人,《科学信号》4:ra30, 2011)。这些研究表明蛋白激酶 CK2 是凋亡途径的全局调节剂。在本文中,我们扩展了对半胱氨酸蛋白酶和 CK2 重叠基序蛋白的分析,以检查 CK2 与特定半胱氨酸蛋白酶的收敛性,并确定已知在细胞中发生磷酸化或切割的 CK2/半胱氨酸蛋白酶底物。鉴于 CK2 的组成性活性和在癌症中的高表达,这些观察结果表明,CK2 调节半胱氨酸蛋白酶途径的能力可能有助于促进癌细胞存活,并为 CK2 的治疗靶向提供了有趣的前景。